[ad_1] Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma [ad_2] Source: Seekingalpha
Browsing: downgraded
[ad_1] Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma [ad_2] Source: Seekingalpha
[ad_1] Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma [ad_2] Source: Seekingalpha
[ad_1] Aadi Bioscience downgraded to Neutral, shares fall [ad_2] Source: Seekingalpha
[ad_1] Aadi Bioscience (NASDAQ:AADI) was downgraded to Neutral from Overweight at Piper Sandler after it introduced that mid-stage examine of its stable tumors candidate was unlikely…
[ad_1] Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket.…
[ad_1] Healthcare companies supplier Premier Inc (NASDAQ:PINC) was downgraded to Hold from Buy at Benchmark on Monday after the corporate guided its FY25-26 outlook under Street…
[ad_1] Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket.…
[ad_1] Healthcare companies supplier Premier Inc (NASDAQ:PINC) was downgraded to Hold from Buy at Benchmark on Monday after the corporate guided its FY25-26 outlook beneath Street…
[ad_1] Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket.…